A Clinical Study to Evaluate the Efficacy and Safety of CKD-351
Conditions: Primary Open Angle Glaucoma; Ocular Hypertension Interventions: Drug: CKD-351; Drug: Latanoprost+Dorzolmamide Sponsor: Chong Kun Dang Pharmaceutical Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 25, 2020 Category: Research Source Type: clinical trials